• FirefoxInstall the new Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.27%

    Agenus Inc. (AGEN)

    -NasdaqCM
    4.68 Mar 26, 4:00PM EDT
    Add to Portfolio
    Prev Close:4.68
    Open:N/A
    Bid:4.54 x 500
    Ask:4.80 x 500
    1y Target Est:9.25
    Beta:1.05
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:N/A - N/A
    52wk Range:2.27 - 6.49
    Volume:0
    Avg Vol (3m):2,157,060
    Market Cap:331.15M
    P/E (ttm):N/A
    EPS (ttm):-0.71
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    AGEN 0.00%331.15M
    ABPIN/A
    DNDNN/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):47.46
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.40
    Quarterly EPS Est (Mar-15) :-0.01
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Agenus Inc., an immunotherapy company, engages in discovering and developing innovative treatments for patients with cancer and other diseases. Its treatments focus on providing therapeutic benefit through modulation of immune function. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback